Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 3
2008 3
2009 1
2010 1
2013 2
2014 3
2015 2
2017 1
2020 3
2021 4
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
A Modified Basophil Activation Test for the Clinical Management of Immediate Hypersensitivity Reactions to Paclitaxel: A Proof-of-Concept Study.
La Sorda M, Fossati M, Graffeo R, Ferraironi M, De Rosa MC, Buzzonetti A, Righino B, Zampetti N, Fattorossi A, Nucera E, Aruanno A, Ferrandina G, Apostol AI, Buonomo A, Scambia G, Sanguinetti M, Battaglia A. La Sorda M, et al. Among authors: buzzonetti a. Cancers (Basel). 2023 Dec 13;15(24):5818. doi: 10.3390/cancers15245818. Cancers (Basel). 2023. PMID: 38136365 Free PMC article.
PD-L1 Expression on Circulating Tumour-Derived Microvesicles as a Complementary Tool for Stratification of High-Grade Serous Ovarian Cancer Patients.
Battaglia A, Piermattei A, Buzzonetti A, Pasciuto T, Zampetti N, Fossati M, Angelico G, Iacobelli V, Nero C, Iannucci V, Scambia G, Fagotti A, Fattorossi A. Battaglia A, et al. Among authors: buzzonetti a. Cancers (Basel). 2021 Oct 16;13(20):5200. doi: 10.3390/cancers13205200. Cancers (Basel). 2021. PMID: 34680346 Free PMC article.
Translational immune correlates of indirect antibody immunization in a randomized phase II study using scheduled combination therapy with carboplatin/paclitaxel plus oregovomab in ovarian cancer patients.
Battaglia A, Buzzonetti A, Fossati M, Scambia G, Fattorossi A, Madiyalakan MR, Mahnke YD, Nicodemus C. Battaglia A, et al. Among authors: buzzonetti a. Cancer Immunol Immunother. 2020 Mar;69(3):383-397. doi: 10.1007/s00262-019-02456-z. Epub 2020 Jan 3. Cancer Immunol Immunother. 2020. PMID: 31897661 Free PMC article. Clinical Trial.
Correction to: Translational immune correlates of indirect antibody immunization in a randomized phase II study using scheduled combination therapy with carboplatin/paclitaxel plus oregovomab in ovarian cancer patients.
Battaglia A, Buzzonetti A, Fossati M, Scambia G, Fattorossi A, Madiyalakan MR, Mahnke YD, Nicodemus C. Battaglia A, et al. Among authors: buzzonetti a. Cancer Immunol Immunother. 2020 Jul;69(7):1389. doi: 10.1007/s00262-020-02537-4. Cancer Immunol Immunother. 2020. PMID: 32219502 Free PMC article.
21 results